Antithrombotic and antiplatelet activities of fenofibrate, a lipid-lowering drug

Atherosclerosis

Volumn 206, Issue 2, 2009, Pages 375-382

  Lee, Jung Jin ^a   Jin, Yong Ri ^b   Yu, Ji Yeon ^a   Munkhtsetseg, Tudev ^a   Park, Eun Seok ^a   Lim, Yong ^a   Kim, Tack Joong ^c   Pyo, Myoung Yun ^d   Hong, Jin Tae ^a   Yoo, Hwan Soo ^a   Kim, Youngsoo ^a   Yun, Yeo Pyo ^a  

^a Chungbuk National University   (South Korea)

^b Maine Medical Center Research Institute   (United States)

^c Yonsei University Wonju   (South Korea)

^d Sookmyung Women's University   (South Korea)

Author keywords

Cytosolic calcium mobilization; Fenofibrate; Thrombosis; Thromboxane A2 receptor

Indexed keywords

ADENOSINE DIPHOSPHATE; ANTILIPEMIC AGENT; ARACHIDONIC ACID; CALCIUM ION; CHOLESTEROL; COLLAGEN; CYCLOOXYGENASE 1; FENOFIBRATE; FERRIC CHLORIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTHROMBIN; THROMBOPLASTIN; THROMBOXANE A2 RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTERY BLOOD FLOW; ARTICLE; BINDING AFFINITY; BLOOD CLOTTING TIME; CALCIUM MOBILIZATION; CAROTID ARTERY; CAROTID ARTERY THROMBOSIS; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CYTOSOL; DRUG DOSE COMPARISON; ENZYME ACTIVITY; ENZYME INHIBITION; EX VIVO STUDY; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOGENESIS; THROMBOSIS PREVENTION; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; ARACHIDONIC ACID; BLOOD COAGULATION; CALCIUM; CYCLOOXYGENASE 1; FENOFIBRATE; FIBRINOLYTIC AGENTS; MALE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; THROMBOSIS;

EID: 70349414649     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.02.034     Document Type: Article

References (50)

1. Steinhubl S., and Moliterno D.J. The role of the platelet in the pathogenesis of atherothrombosis. Am J Cardiovasc Drugs 5 (2005) 399-408
2. Chou J., Mackman N., Merrill-Skoloff G., et al. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 104 (2004) 3190-3197
3. Furie B., and Furie B.C. The molecular basis of blood coagulation. Cell 53 (1988) 505-518
4. Mann K.G. Biochemistry and physiology of blood coagulation. Thromb Haemost 82 (1999) 165-174
5. Monroe D.M., Hoffman M., and Roberts H.R. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 22 (2002) 1381-1389
6. Genton E., Clagett G.P., and Salzman E.W. Antithrombotic therapy in peripheral vascular disease. Chest 89 (1986) 75S-81S
7. Hjemdahl-Monsen C.E., Lewis H.D., Cairns J., Chesebro J.H., and Fuster V. Role of antithrombotic therapy in unstable angina, myocardial infarction and sudden death. J Am Coll Cardiol 8 (1986) 67B-75B
8. Sherman D.G., and Hart R.G. Thromboembolism and antithrombotic therapy in cerebrovascular disease. J Am Coll Cardiol 8 (1986) 88B-97B
9. Grande P., Grauholt A.M., and Madsen J.K. Unstable angina pectoris platelet behavior and prognosis in progressive angina and intermediate coronary syndrome. Circulation 81 (1990) I16-I19
10. Cowan D.H. Platelet adherence to collagen: role of prostaglandin-thromboxane synthesis. Br J Haematol 49 (1981) 425-434
11. Cowan D.H., Robertson A.L., Shook P., and Giroski P. Platelet adherence to collagen: role of plasma, ADP, and divalent cations. Br J Haematol 47 (1981) 257-267
12. Sixma J.J., van Zanten G.H., Huizinga E.G., et al. Platelet adhesion to collagen: an update. Thromb Haemost 78 (1997) 434-438
13. Nieswandt B., and Watson S.P. Platelet-collagen interaction: is GPVI the central receptor?. Blood 102 (2003) 449-461
14. Gibbins J.M. Platelet adhesion signalling and the regulation of thrombus formation. J Cell Sci 117 (2004) 3415-3425
15. Miller D.B., and SJ D. Clinical pharmacokinetics of fibric acid derivatives (fibrates). Clin Pharmacokinet 34 (1998) 155-162
16. Froman B.M., Chen J., and Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferators-activated receptors alpha and delta. Proc Natl Acad Sci USA 94 (1997) 4312-4317
17. Kliewer S.A., Sundseth S.S., and Jones S.A. Fatty acids and eicosanoids regulate gene expression through direct interactions with the peroxisome proliferators-activated receptor α and γ. Proc Natl Acad Sci USA 94 (1997) 4318-4323
18. Staels B., Dallongeville J., and Auwerx J. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98 (1998) 2088-2093
19. Brown W.V. Focus on fenofibrate. Hosp Pract (Off Ed) 23 (1988) 31-40
20. Neve B.P., Corseaux D., Chinetti G., et al. PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages. Circulation 103 (2001) 207-212
21. Golledge J., Mangan S., and Clancy P. Effects of peroxisome proliferator-activated receptor ligands in modulating tissue factor and tissue factor pathway inhibitor in acutely symptomatic carotid atheromas. Stroke 38 (2007) 1501-1508
22. Undas A., Celinska-Löwenhoff M., Domagala T.B., et al. Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemia. Thromb Haemost 94 (2005) 193-199
23. Roberts W.C. Safety of fenofibrate-US and worldwide experience. Cardiology 76 (1989) 169-179
24. Blane G.F. Comparative toxicity and safety profile of fenofibrate and other fibric acid derivatives. Am J Med 83 (1987) 26-36
25. Blane G.F. Review of European clinical experience with fenofibrate. Cardiology 76 (1989) 1-13
26. Jin Y.R., Yu J.Y., Lee J.J., et al. Antithrombotic and antiplatelet activities of Korean red ginseng extract. Basic Clin Pharmacol 100 (2007) 170-175
27. Jin Y.R., Ryu C.K., Moon C.K., Cho M.R., and Yun Y.P. Inhibitory effects of J78, a newly synthesized 1,4-naphthoquinone derivative, on experimental thrombosis and platelet aggregation. Pharmacology 70 (2004) 195-200
28. 2+ mobilization. J Pharmacol Exp Ther 312 (2005) 214-219
29. Born G.V., and Cross M.J. The aggregation of blood platelets. J Physiol 168 (1963) 178-195
30. Jin Y.R., Han X.H., Zhang Y.H., et al. Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-gamma2 phosphorylation and cyclooxygenase-1 activity. Atherosclerosis 294 (2006) 144-152
31. Kurz K.D., Main B.W., and Sandusky G.E. Rat model of arterial thrombosis induced by ferric chloride. Thrombo Res 60 (1990) 269-280
32. Lockyer S., and Kambayashi J. Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis. J Cardiol Pharmacol 33 (1999) 718-725
33. Furie B., and Furie B.C. Thrombus formation in vivo. J Clin Invest 115 (2005) 3355-3362
34. Farrehi P.M., Ozaki C.K., Carmeliet P., and Fay W.P. Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice. Circulation 97 (1998) 1002-1008
35. Park H.J., Rhee M.H., Park K.M., Nam K.Y., and Park K.H. Effect of non-saponin fraction from Panax ginseng on cGMP and thromboxane A2 in human platelet aggregation. J Ethnopharmacol 49 (1995) 157-162
36. Cui X., Sakaguchi T., Shirai Y., and Hatakeyama K. Orally administered Panax ginseng extract decreases platelet adhesiveness in 66% hepatectomized rats. Am J Chin Med 27 (1999) 251-256
37. Yun Y.P., Do J.H., Ko S.R., and Ryu S.Y. Effects of Korean red ginseng and its mixed prescription on the high molecular weight dextran-induced blood stasis in rats and human platelet aggregation. J Ethnopharmacol 77 (2001) 259-264
38. Jackson S.P., Nesbitt W.S., and Kulkarni S. Signaling events underlying thrombus formation. J Thromb Haemost 1 (2003) 1602-1612
39. Niiya K., Hodson E., and Bader R. Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation: relationship to the binding of fibrinogen and platelet aggregation. Blood 70 (1987) 475-483
40. Godfraind T. Calcium antagonists and vasodilation. Pharmacol Ther 64 (1994) 37-75
41. Heemskerk J.W.M., and Sage O. Calcium signaling in platelets and other cells. Platelets 5 (1994) 295-316
42. Oates J.A., Hardman J.G., Limbird L.E., et al. Antihypertensive agents and the drug therapy of hypertension. The pharmacological basis of therapeutics. 9th ed. (1996), McGraw-Hill, New York p. 80-808
43. Berridge M.J. Inositol triphosphate and calcium signaling. Nature 361 (1993) 315-325
44. Needleman P., Turk J., Jakschik B.A., Morrison A.R., and Lefkowith J.B. Arachidonic acid metabolism. Annu Rev Biochem 55 (1986) 69-102
45. Holmsen H., and Dangelmarier C.A. Measurement of secretion of serotonin. Methods Enzymol 169 (1989) 205-210
46. Blockmans D., Deckmyn H., and Vermylen J. Platelet activation. Blood Rev 9 (1995) 143-156
47. Johnson G.J., Leis L.A., and Francis G.S. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets. Circulation 73 (1986) 847-854
48. McNicol A., and Shibou T.S. Translocation and phosphorylation of cytosolic phospholipase A2 in activated platelets. Thromb Res 92 (1998) 19-26
49. Parise L.V., Venton D.L., and Le Breton G.C. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction. J Pharmacol Exp Ther 228 (1984) 240-244
50. Coleman R.A., Smith W.L., and Narumiya S. International Union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46 (1994) 205-229